p53 constrains progression to anaplastic thyroid carcinoma in a <i>Braf</i> -mutant mouse model of papillary thyroid cancer
David G. McFadden(Southwestern Medical Center), Tyler Jacks(Howard Hughes Medical Institute), Amanda Vernon(Massachusetts Institute of Technology), Peter M. Sadow(Massachusetts Eye and Ear Infirmary), Raúl Martinez-McFaline(Massachusetts Institute of Technology), Denise M. Crowley(Massachusetts Institute of Technology), Martin McMahon(UCSF Helen Diller Family Comprehensive Cancer Center), Arjun Bhutkar(Massachusetts Institute of Technology), Philip M. Santiago(Massachusetts Institute of Technology)
Cited by 169
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k